WellDoc’s Bluestar App launched in India to Improve Diabetes Care
Dr. Avantika Batish is working as Director Strategy and Healthcare at International Health Emergency Learning and Preparedness. Also, guest faculty for MBA (HR) and MBA Healthcare Management at various B-Schools and is a soft skills trainer.
The International Diabetes Foundation has made predictions that diabetes could affect 123 million Indian citizens by 2040 and also their statistics show that the treatment for diabetes complications costs more than 670 billion US dollars a year globally, and that the disease claims the lives of five million people worldwide each year.
In this light IFC, a member of the World Bank Group; WellDoc, a US-based digital health startup and Max Healthcare, a leading Indian healthcare provider recently launched a cutting-edge mobile application in India to improve diabetes care.
The app will initially be piloted with a select group of patients in New Delhi, which allows them to transform their smartphone, tablet or personal computer into a personal health advisor.
The app will be tailored to the Indian market to account for specific medications and local diets, allowing patients to enter details of their meals and receive instant advice on the optimal medication and dosage.
WellDoc’s BlueStar® application is a mobile health monitoring tool that helps adults living with type 2 diabetes and their doctors drive behavioral and clinical change. The app analyzes diabetes data entered by the patient, including blood glucose levels and medications, and delivers curated analytics to a patient’s healthcare team to improve decisions and better manage the disease.